CCL2 and breast carcinoma: Doxorubicin and paclitaxel treatment results in the recruitment of innate immune cells and CSF1R-dependent macrophages infiltration in PyMT-MMTV mammary carcinoma through an increase of CCL2, CXCL2, CSF-1, interleukin-34 and vascular permeability [133,134].